The UTEL OTDR can be connected to the input of a UTEL OS-36 to provide test access for multiple fibres. The Optical Test Access Switches can be organised in a cascaded arrangement, which means a single UTEl OTDR can test an entire Optical Distribution Frame(ODF). The OTDR can be controlled remotely using TL1, XML or UTELs bespoke test management software.
Aetna considers pembrolizumab (Keytruda) medically necessary for the following indications: 1  Colorectal cancer - single agent therapy for. Primary treatment for unresectable metachronous metastases and previous adjuvant FOLFOX or CapeOX within the past 12 months; or.
Keytruda (pembrolizumab) is a medication approved for people who have advanced melanoma that can't be removed surgically and is no longer responding to other treatments.Keytruda works by blocking a certain process in cells that prevents the immune system from attacking melanoma cells.he Food and Drug Administration (FDA) gave accelerated approval to Keytruda based on clinical trial results suggesting that the drug is an improvement on other therapies. In trials, 24% of patients had their tumors shrink while taking the drug, and the benefits lasted more than 8.5 months in most.